
Sign up to save your podcasts
Or


Celgene buys Juno Theraputics. Halliburton delivers results in the 4th quarter and optimism for 2018. Abercrombie & Fitch soars 10% on a better-than-expected holiday season. Jason Moser and Taylor Muckerman analyze those stories and discuss opportunities in the energy industry.
By The Motley Fool4.7
16041,604 ratings
Celgene buys Juno Theraputics. Halliburton delivers results in the 4th quarter and optimism for 2018. Abercrombie & Fitch soars 10% on a better-than-expected holiday season. Jason Moser and Taylor Muckerman analyze those stories and discuss opportunities in the energy industry.

3,218 Listeners

1,489 Listeners

807 Listeners

945 Listeners

523 Listeners

1,165 Listeners

2,182 Listeners

825 Listeners

1,422 Listeners

1,038 Listeners

9,719 Listeners

196 Listeners

829 Listeners

87 Listeners

591 Listeners

1,030 Listeners

53 Listeners